GLYCEROPHOSPHATE DE SODIUM KABI 216 mg/ml (1 mmol/ml), concentrate for solution for infusion 20 ampoules of 20 ml
Active ingredients: Sodium 1-glycerophosphate, Sodium 2-glycerophosphate pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusion20 ampoules of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLYCEROPHOSPHATE DE SODIUM KABI 216 mg/mL (1 mmol/mL), solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 20 ampoules polypropylène de 20 mL
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61396856CIP73028862CIP133400930288627Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GLYCÉROPHOSPHATE DE SODIUM ANHYDREsolution | 216 mg · 1 ml de solution à diluer | FT |
| GLYCÉROPHOSPHATE DE SODIUM PENTAHYDRATÉsolution | 306,1 mg · 1 ml de solution à diluer | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.